| Dr Dion Grant Fisher, MD | |
|
12277 De Paul Dr, Suite 504, Bridgeton, MO 63044-2516 | |
| (314) 298-3893 | |
| (314) 851-4408 |
| Full Name | Dr Dion Grant Fisher |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 12277 De Paul Dr, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285846055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2007010564 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Multispecialty Group Inc | 1658365572 | 151 |
News Archive
Some young adults who were bullied as a child could have a greater risk of ongoing depression due to a mix of genetic and environmental factors according to a new study from the University of Bristol.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
The CMS has extended the possible date of Parkland Health and Hospital System's termination from the Medicare program to Sept. 30 from Sept. 2 in order to give state surveyors more time to complete their reports. The 672-bed Parkland received word Aug. 9 that it was under threat of losing its status as a Medicare provider, and after submitting its plan of action (PDF) on how it would correct the problems by an Aug. 20 deadline.
Allergan, Inc. and Serenity Pharmaceuticals, LLC today announced a global agreement for the development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.
› Verified 7 days ago
| Entity Name | American Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559532 PECOS PAC ID: 1658365572 Enrollment ID: O20040413001412 |
News Archive
Some young adults who were bullied as a child could have a greater risk of ongoing depression due to a mix of genetic and environmental factors according to a new study from the University of Bristol.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
The CMS has extended the possible date of Parkland Health and Hospital System's termination from the Medicare program to Sept. 30 from Sept. 2 in order to give state surveyors more time to complete their reports. The 672-bed Parkland received word Aug. 9 that it was under threat of losing its status as a Medicare provider, and after submitting its plan of action (PDF) on how it would correct the problems by an Aug. 20 deadline.
Allergan, Inc. and Serenity Pharmaceuticals, LLC today announced a global agreement for the development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dion Grant Fisher, MD Po Box 23340, Saint Louis, MO 63156-3340 Ph: (314) 298-3893 | Dr Dion Grant Fisher, MD 12277 De Paul Dr, Suite 504, Bridgeton, MO 63044-2516 Ph: (314) 298-3893 |
News Archive
Some young adults who were bullied as a child could have a greater risk of ongoing depression due to a mix of genetic and environmental factors according to a new study from the University of Bristol.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
The CMS has extended the possible date of Parkland Health and Hospital System's termination from the Medicare program to Sept. 30 from Sept. 2 in order to give state surveyors more time to complete their reports. The 672-bed Parkland received word Aug. 9 that it was under threat of losing its status as a Medicare provider, and after submitting its plan of action (PDF) on how it would correct the problems by an Aug. 20 deadline.
Allergan, Inc. and Serenity Pharmaceuticals, LLC today announced a global agreement for the development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.
› Verified 7 days ago
Robert M Fischer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12303 De Paul Dr, Radiology Dept, Bridgeton, MO 63044 Phone: 314-770-9393 Fax: 314-770-9997 | |
Dr. Ashfaq Ullah, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 12255 De Paul Dr Ste 500, Bridgeton, MO 63044 Phone: 314-209-5180 | |
Sean T Mclaughlin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr, Suite 504, Bridgeton, MO 63044 Phone: 314-298-3893 Fax: 314-851-4408 | |
Dr. Raymond Frederick Mohrman Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12266 De Paul Dr Ste 300, Bridgeton, MO 63044 Phone: 314-291-8824 | |
Navid S Siddiqui, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr Ste 600, Bridgeton, MO 63044 Phone: 314-209-5100 | |
Robert Byrne, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Suite 700, Bridgeton, MO 63044 Phone: 314-739-4166 Fax: 314-739-2485 | |
Melvin Boris Saltzman, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr, Ste 404, Bridgeton, MO 63044 Phone: 314-770-1000 Fax: 314-770-2456 |